Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
Technology:
Drug Design
Number Of Exists:
N/A
Investment Stage:
N/A
Founded Date:
2016
Headquarters:
Budapest, Budapest, Hungary
Employee Number:
Undisclosed
Investor Type:
N/A
Funding Status:
Seed
Industry:
Drug Discovery
%20.jpg)